Quantum BioPharma Ltd.

CNSX:QNTM Stok Raporu

Piyasa değeri: CA$12.2m

Quantum BioPharma Yönetim

Yönetim kriter kontrolleri 3/4

Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 6.29% of the company’s shares, worth CA$764.19K. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.

Anahtar bilgiler

Zeeshan Saeed

İcra Kurulu Başkanı

US$599.9k

Toplam tazminat

CEO maaş yüzdesi37.1%
CEO görev süresi3.3yrs
CEO sahipliği6.3%
Yönetim ortalama görev süresi3.2yrs
Yönetim Kurulu ortalama görev süresi3.2yrs

Son yönetim güncellemeleri

Recent updates

We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Apr 13
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Dec 17
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Here's Why We're Watching FSD Pharma's (CSE:HUGE) Cash Burn Situation

Aug 25
Here's Why We're Watching FSD Pharma's (CSE:HUGE) Cash Burn Situation

How Many FSD Pharma Inc. (CSE:HUGE) Shares Did Insiders Buy, In The Last Year?

Feb 13
How Many FSD Pharma Inc. (CSE:HUGE) Shares Did Insiders Buy, In The Last Year?

CEO Tazminat Analizi

Zeeshan Saeed'un ücretlendirmesi Quantum BioPharma'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$600kUS$223k

-US$18m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$774kUS$239k

-US$27m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$1mUS$225k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$899kUS$212k

-US$28m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$2mUS$249k

-US$34m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$503kUS$183k

-US$17m

Tazminat ve Piyasa: Zeeshan's total compensation ($USD599.87K) is above average for companies of similar size in the Canadian market ($USD171.96K).

Tazminat ve Kazançlar: Zeeshan's compensation has been consistent with company performance over the past year.

CEO

Zeeshan Saeed (54 yo)

3.3yrs

Görev süresi

US$599,873

Tazminat

Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Zeeshan Saeed
Founder3.3yrsUS$599.87k6.29%
CA$ 764.2k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
CA$ 652.0k
Donal Carroll
CFO & COO3.3yrsUS$602.87k4.44%
CA$ 539.3k
Nathan Coyle
Controllerless than a yearUS$178.21k0.13%
CA$ 16.3k
Lakshmi Kotra
CEO of Lucid & Director3.2yrsUS$521.97k1.17%
CA$ 142.7k
Jason Sawyer
Head of Finance & Mergers and Acquisitionsless than a yearVeri yokVeri yok
Maryann Adesso
Corporate Secretaryno dataVeri yokVeri yok
Randell Mack
President of FSD BioSciences3.7yrsVeri yokVeri yok
Andrzej Chruscinski
Vice President of Clinical & Scientific Affairs of Lucidno dataUS$110.30k0%
CA$ 0
Kevin Cassidy
Vice President of Quality-Lucidno dataUS$144.82kVeri yok

3.2yrs

Ortalama Görev Süresi

48yo

Ortalama Yaş

Deneyimli Yönetim: QNTM's management team is considered experienced (3.2 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Zeeshan Saeed
Founder3.5yrsUS$599.87k6.29%
CA$ 764.2k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
CA$ 652.0k
Lakshmi Kotra
CEO of Lucid & Director2yrsUS$521.97k1.17%
CA$ 142.7k
Daniele Piomelli
Member of Research & Clinical Advisory Board2.8yrsVeri yokVeri yok
Eleanor Fish
Member of Research & Clinical Advisory Board3yrsVeri yokVeri yok
Hance Clarke
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Eric Hoskins
Independent Director1.5yrsVeri yokVeri yok
Adnan Bashir
Independent Director3.4yrsUS$139.37k0.0077%
CA$ 938.4
Peter Stys
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Shannon Dunn
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Albert Wong
Member of Research & Clinical Advisory Board3.2yrsVeri yokVeri yok
Joga Gobburu
Member of Regulatory Advisory Board3yrsVeri yokVeri yok

3.2yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: QNTM's board of directors are considered experienced (3.2 years average tenure).